Amyloid-beta precursor protein
From WikiMD's Wellness Encyclopedia
Amyloid-beta precursor protein
The Amyloid-beta precursor protein (APP) is a transmembrane protein that plays a crucial role in the pathogenesis of Alzheimer's disease. It is encoded by the APP gene located on chromosome 21 in humans. APP is processed through two main pathways: the amyloidogenic pathway and the non-amyloidogenic pathway.
Structure[edit | edit source]
APP is a type I transmembrane protein that undergoes post-translational modifications, including glycosylation and phosphorylation. It consists of a large extracellular domain, a single transmembrane domain, and a short cytoplasmic tail. The extracellular domain contains the amyloid-beta (Aβ) region, which is cleaved to form Aβ peptides.
Function[edit | edit source]
The exact function of APP is not fully understood, but it is believed to be involved in neuronal growth, synapse formation, and repair processes in the brain. APP is processed by enzymes called secretases, which cleave it at different sites to produce various fragments. The amyloidogenic pathway leads to the formation of Aβ peptides, which can aggregate and form plaques in the brain, a hallmark of Alzheimer's disease.
Role in Alzheimer's Disease[edit | edit source]
Mutations in the APP gene or abnormalities in its processing can lead to the accumulation of Aβ peptides, which are toxic to neurons and disrupt normal brain function. This accumulation is a key event in the development of Alzheimer's disease. The Aβ peptides can aggregate to form insoluble plaques, which contribute to neurodegeneration and cognitive decline.
Clinical Significance[edit | edit source]
Research on APP and its processing pathways is essential for understanding the mechanisms underlying Alzheimer's disease and developing potential therapeutic interventions. Targeting the processing of APP to reduce the production of Aβ peptides is a promising approach for treating Alzheimer's disease.
See also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.